Clinical Trial Update: Inosine Reverse Chemo Resistance in Triple Negative Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating inosine to reverse chemotherapy resistance in triple-negative breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• Inosine (inosine)

Snippet

Sponsor: Fudan University | Conditions: Triple-negative Breast Cancer | Phase 2 | Status: COMPLETED